CÚRAM is the National Centre for Research in Medical Devices, backed by Science Foundation Ireland and industry funding. The centre positions Ireland as the driver in developing medical device technologies and strengthens Ireland’s standing as a major global hub for MedTech R&D. Our devices are developed through strong collaborations with industry partners, regulators and hospital groups to enable their rapid translation to the clinic.
CÚRAM researchers are designing and manufacturing the next generation of ‘smart’ medical devices and implants to improve health outcomes and enhance quality of life for patients with chronic illnesses. CÚRAM’s innovative approach incorporates biomaterials, drug delivery, cell-based technologies, glycosciences and device design to enhance, develop and validate both traditional and new combinational medical devices from molecular design stage to implant manufacturing.
Backed by €41.3m in SFI and industry funding, CÚRAM’s 150-plus researchers are designing and manufacturing medical devices and implants to respond to the body’s environment and to deliver therapeutic agents exactly where they are needed. CÚRAM’s outputs will particularly benefit patients with chronic diseases in the cardiovascular, neural, musculoskeletal, respiratory, renal, urology and soft tissue space.
CÚRAM includes more than 24 industry partners, including Irish companies and multinationals. CÚRAM also supports product development and the creation of spin-out companies.
24+ Industry partners including:
CÚRAM has developed a public engagement programme to support SFI’s Agenda 2020 goal of having ‘the most scientifically informed and engaged public’. The programme includes:
Prof Abhay Pandit - Centre Director
Abhay Pandit is Professor of Biomaterials at the National University of Ireland, Galway. In 2012 Prof Pandit was inducted as an International Fellow by the International Union of Societies for Biomaterials Science and Engineering (IUSBSE). He was elected Council Member of the European Society for Biomaterials Society in 2013. He has received numerous honours, including the Johnson & Johnson Healthcare Innovation Programme Award and the Academic/Emerging Medical Technology Company of the Year-Silver Award for 2013. In his industry career, Prof Pandit secured Food and Drug Administration clearance for a commercial wound dressing and Investigational Device Exemption approval for a collagen-based vascular sealant.
Dr Stefania Spada - Scientific Programme Manager
Dr. Neil Ferguson - Industry Programme Manager
Claire Riordan - Scientific Engagement Associate